Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 2

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell 10Lymphoma, Mantle-Cell 9Lymphoma, Large B-Cell, Diffuse 4Lymphoma, Follicular 4Lymphoma, B-Cell 4Waldenstrom Macroglobulinemia 3Recurrence 3Lymphoma, B-Cell, Marginal Zone 3Lymphoma, Non-Hodgkin 2Lymphoma 2Neoplasms 1Multiple Myeloma 1Mature B-Cell Malignancies 1Hematologic Diseases 1

Interventions

Cyclophosphamide 30Rituximab 26Biopsy 23Specimen Handling 20Magnetic Resonance Spectroscopy 18fludarabine 14Prednisone 13Vincristine 11obinutuzumab 10Lenalidomide 10Etoposide 10Doxorubicin 10Bendamustine Hydrochloride 9pembrolizumab 7venetoclax 6fludarabine phosphate 6X-Rays 6Tacrolimus 6Nuclear Medicine Department, Hospital 6Dexamethasone 6Bortezomib 6trametinib 5ibrutinib 5glofitamab 5acalabrutinib 5Mycophenolic Acid 5Gemcitabine 5Crizotinib 5Busulfan 5copanlisib 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Lymphoma × zanubrutinib × 90 days × Clear all
NCT05389293 2026-05-19

A Study of Mosunetuzumab Alone or With Zanubrutinib in People With Follicular Lymphoma

Memorial Sloan Kettering Cancer Center

Phase 2 Recruiting
152 enrolled
Lymphoid

Lymphoma, Lymphoma, Follicular

NCT04662255 2026-05-15

BRUIN-MCL-321

Eli Lilly and Company

Phase 3 Active not recruiting
500 enrolled
Lymphoid

Hematologic Diseases, Lymphoma, Lymphoma, Non-Hodgkin, Lymphoma, B-Cell, Lymphoma, Mantle-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡